EUVIMEDEUVIMED entdecken
Open Access

A retrospective evaluation of clinical outcomes in the use of inhaled nitric oxide in acute respiratory distress syndrome caused by COVID-19: The NITRICOVID study

Mohamed Zuhail Kizhakka Peediyakkal, Muna A Rahman Al Maslamani, Nevin Kannappilly, Saifil Sidhique, Mohamed Aboukamar, Sreekanth Komath Mohan, Jintu Iype, Virendra Pratap Chaudhary, Ashib Thurakkal, Karimulla Shakeer Shaik, Solaiman Allafi, Abdulqadir Nashwan und 1 weitere

Qatar Medical Journal · 2026 · 2026 (1)

DOI: 10.5339/qmj.2026.13 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Qatar Medical Journal, 2026. Verfasst von Mohamed Zuhail Kizhakka Peediyakkal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hamad Medical Corporation, Hamad Medical City, Doha, Qatar *Email: mpeediyakkal2@hamad.qa. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute respiratory distress syndrome (ARDS) remains a leading cause of mortality among critically ill patients with COVID-19. Inhaled nitric oxide (iNO), a selective pulmonary vasodilator, is often used as rescue therapy to improve oxygenation; however, its impact on survival remains uncertain.

Objective

To evaluate the clinical outcomes of iNO therapy in patients with COVID-19-related ARDS and to stratify patients into Early, Delayed, and Non-Responder groups based on the timing of their oxygenation response.

Methods

A retrospective cohort study of 99 patients with COVID-19-related ARDS who received iNO was conducted. Patients were categorized as: Early Responders: ≥20% improvement in the PaO 2 /FiO 2 ratio within 8 h; Delayed Responders: ≥20% improvement in the PaO 2 /FiO 2 ratio between 8 and 24 h; Non-Responders:

Schlagwörter

Stichwörter der Autor:innen

ARDSCOVID-19mechanical ventilationnitric oxide

Autor:innen und Institutionen

  • Hamad Medical Corporation, Hamad Medical City, Doha, Qatar *Email: mpeediyakkal2@hamad.qa.

Zitieren

APA

Peediyakkal, M. Z. K., Al Maslamani, M. A. R., Kannappilly, N., Sidhique, S., Aboukamar, M., Mohan, S. K., Iype, J., Chaudhary, V. P., Thurakkal, A., Shaik, K. S., Allafi, S., Nashwan, A., & Al LObaney, N. F. S. (2026). A retrospective evaluation of clinical outcomes in the use of inhaled nitric oxide in acute respiratory distress syndrome caused by COVID-19: The NITRICOVID study. Qatar Medical Journal, 2026(1). https://doi.org/10.5339/qmj.2026.13

Vancouver

Peediyakkal MZK, Al Maslamani MAR, Kannappilly N, Sidhique S, Aboukamar M, Mohan SK, et al. A retrospective evaluation of clinical outcomes in the use of inhaled nitric oxide in acute respiratory distress syndrome caused by COVID-19: The NITRICOVID study. Qatar Medical Journal. 2026;2026(1). doi:10.5339/qmj.2026.13

BibTeX
@article{Peediyakkal2026,
  author = {Peediyakkal, Mohamed Zuhail Kizhakka and Al Maslamani, Muna A Rahman and Kannappilly, Nevin and Sidhique, Saifil and Aboukamar, Mohamed and Mohan, Sreekanth Komath and Iype, Jintu and Chaudhary, Virendra Pratap and Thurakkal, Ashib and Shaik, Karimulla Shakeer and Allafi, Solaiman and Nashwan, Abdulqadir and Al LObaney, Nabeel F Suleiman},
  title = {A retrospective evaluation of clinical outcomes in the use of inhaled nitric oxide in acute respiratory distress syndrome caused by COVID-19: The NITRICOVID study},
  journal = {Qatar Medical Journal},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.5339/qmj.2026.13}
}
Kostenlos starten →